Screener
CONMED CNMD Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Research and development expense | 15,500 | 14,138 | 31,833 | 27,084 |
| Operating expenses | 161,053 | 150,159 | 319,085 | 311,952 |
| Income from operations | 36,405 | 38,161 | 61,820 | 54,119 |
| Interest expense | 7,883 | 7,824 | 14,943 | 16,110 |
| Other (income) / expense | (2,825) | 418 | (2,825) | 418 |
| Income before income taxes | 31,347 | 29,919 | 49,702 | 37,591 |
| Provision for income taxes | 8,276 | 8,498 | 12,803 | 10,134 |
| Net income | $23,071 | $21,421 | $36,899 | $27,457 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's interest expense?
- CONMED (CNMD) reported interest expense of $7.88M in Q2 2026.
- How has CONMED's interest expense changed year-over-year?
- CONMED's interest expense increased by 0.8% year-over-year, from $7.82M to $7.88M.
- What is the long-term trend for CONMED's interest expense?
- Over 4 years (2021 to 2025), CONMED's interest expense has grown at a -3.3% compound annual growth rate (CAGR), from $35.48M to $31.09M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about CONMED's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude